Search results for "Mach"

showing 10 items of 3360 documents

''Modulation of Anticipatory Postural Activity For Multiple Conditions of A Whole-body Pointing Task''

2012

Tolambiya, A. | Chiovetto, E. | Pozzo, T. | Thomas, E.; International audience; ''This is a study on associated postural activities during the anticipatory segments of a multijoint movement. Several previous studies have shown that they are task dependant. The previous studies, however, have mostly been limited in demonstrating the presence of modulation for one task condition, that is, one aspect such as the distance of the target or the direction of reaching. Real-life activities like whole-body pointing, however, can vary in several ways. How specific is the adaptation of the postural activities for the diverse possibilities of a whole-body pointing task? We used a classification paradig…

AdultMalemedicine.medical_specialtyCORTEXSupport Vector MachineMovementPostureEMG ANALYSISAdaptation (eye)CLASSIFICATIONTask (project management)Physical medicine and rehabilitationModulation (music)medicineMotor activity''VOLUNTARY MOVEMENTSCommunicationCOORDINATIONbusiness.industryMovement (music)General NeuroscienceTARGET DISTANCEFeed forwardMotor controlBrainElectroencephalographyHUMANSAnticipation PsychologicalCLASSIFICATION''EQUILIBRIUMADJUSTMENTS[ SCCO.NEUR ] Cognitive science/NeurosciencePATTERNSVOLUNTARY MOVEMENTSbusinessPsychologyWhole bodyPsychomotor Performance
researchProduct

Cryotherapy for liver metastases

2000

Cryotherapy is undergoing a renaissance in the treatment of nonresectable liver tumors. In a prospective case control study we assessed the morbidity, mortality, and efficacy of hepatic cryotherapy for liver metastases. Between January 1996 and September 1999 a total of 54 cryosurgical procedures were performed on 49 patients (median age 66 years, 21 women) with liver metastases. Patient, tumor, and operative details were recorded prospectively. Liver metastases originated from colorectal cancer (n=37), gastric cancer (n=3), renal cell carcinoma (n=2), and other primaries (n=7). Median follow-up was 13 months (1-32). The median number of liver metastases was 3 (range 1-10) with a median dia…

AdultMalemedicine.medical_specialtyColorectal cancermedicine.medical_treatmentCryotherapyCryosurgeryMetastasisStomach NeoplasmsRenal cell carcinomaInternal medicinemedicineHumansProspective StudiesAgedTumor markerbusiness.industryLiver NeoplasmsGastroenterologyCancerCryoablationMiddle AgedHepatologymedicine.diseaseSurgeryTreatment OutcomeCase-Control StudiesFemaleMorbidityNeoplasm Recurrence LocalColorectal NeoplasmsbusinessInternational Journal of Colorectal Disease
researchProduct

Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum.

1996

BACKGROUND: The presence of gastric metaplasia allows helicobacter pylori to colonise the duodenum and this condition is thought to be acquired as a response to acid hypersecretion. This functional disorder, however, is present only in a subgroup of duodenal ulcer patients and, in addition, surface gastric metaplasia has been frequently found in the proximal duodenum of normal subjects and patients with non-ulcer dyspepsia, who cannot be certainly considered as acid hypersecretors. AIMS: To clarify the role of acid in inducing gastric type epithelium in the duodenum. This study aimed at assessing whether the pattern of circadian gastric acidity differs between H pylori positive duodenal ulc…

AdultMalemedicine.medical_specialtyDuodenumSpirillaceaeGastroenterologyEpitheliumHelicobacter InfectionsGastric AcidInternal medicineMetaplasiaBiopsymedicineHumansAntrumMonitoring PhysiologicAnalysis of VarianceMetaplasiabiologymedicine.diagnostic_testHelicobacter pyloribusiness.industrydigestive oral and skin physiologyStomachGastroenterologyHistologyHelicobacter pyloriHydrogen-Ion ConcentrationMiddle Agedbiology.organism_classificationdigestive system diseasesCircadian Rhythmmedicine.anatomical_structureGastric MucosaDuodenal UlcerDuodenumFemaleGastritismedicine.symptombusinessResearch Article
researchProduct

Postprandial thermogenesis and alimentary sensory stimulation in human subjects

1999

OBJECTIVE: To study the role of alimentary sensory stimulation on the thermic effect of food. SUBJECTS: Nine male healthy volunteers (age: 20-34y, body mass index (BMI): 17.4-25.3 kg/m 2 ). DESIGN AND MEASUREMENTS: Four experimental situations were investigated on different days. Subjects: 1) ate a four course meal containing 2582kJ (meal), 2) saw, smelt and tasted the same courses (alimentary sensory stimulation), 3) saw, smelt and tasted non-alimentary substances (non-alimentary sensory stimulation), 4) received directly into the stomach the previous meal (tube feeding). Energy expenditure (EE) was measured over a 20 min rest period, then for 110 min. RESULTS: The changes over midday rest…

AdultMalemedicine.medical_specialtyEpinephrineEndocrinology Diabetes and MetabolismSensationMedicine (miscellaneous)Sensory systemBody Mass IndexEatingNorepinephrineInternal medicineHumansMedicineMealNutrition and DieteticsSensory stimulation therapybusiness.industryStomachPostprandial Periodmedicine.anatomical_structureEndocrinologyPostprandialSpecific dynamic actionEnergy MetabolismbusinessThermogenesisBody mass indexBody Temperature RegulationInternational Journal of Obesity
researchProduct

Clinicopathological characteristics of Epstein-Barr virus-positive gastric cancer in Latvia

2019

Objective Epstein-Barr virus (EBV)-associated gastric cancer has been proposed to be a distinct gastric cancer molecular subtype. The prognostic significance of EBV infection in gastric cancer remains unclear and needs further investigation. Our study aimed to analyze EBV-positive and EBV-negative gastric cancer patients regarding their personal and tumor-related characteristics, and compare their overall survival. Methods Gastric cancer patients consecutively treated at the Riga East University Hospital during 2009-2016 were identified retrospectively. Tumor EBV status was determined by in-situ hybridization for EBV-encoded RNA (EBER). Information about clinicopathological characteristics …

AdultMalemedicine.medical_specialtyEpstein-Barr Virus InfectionsComorbidityKaplan-Meier EstimateAdenocarcinomaGastroenterologyHospital recordsArticle03 medical and health sciencesYoung Adult0302 clinical medicineAge DistributionStomach NeoplasmsInternal medicinehemic and lymphatic diseasesmedicineHumansStage (cooking)Sex DistributionAgedNeoplasm StagingProportional Hazards ModelsRetrospective StudiesAged 80 and overHepatologyStage I Gastric Cancerbusiness.industryHazard ratioSmokingGastroenterologyCancerEpstein-Barr Virus PositiveMiddle AgedOverweightUniversity hospitalmedicine.diseasePrognosisLatviaConfidence intervalSurvival Rate030220 oncology & carcinogenesis030211 gastroenterology & hepatologyFemaleNeoplasm Gradingbusiness
researchProduct

Survival of stomach and esophagus cancer patients in Germany in the early 21st century

2012

Esophagus and stomach cancers are associated with poor prognosis. But most published population-based cancer survival estimates for stomach and esophagus cancer refer to survival experience of patients diagnosed in the 1990s or earlier years. The aim of this study was to provide up-to-date survival estimates and trends for patients with stomach and esophagus cancer in Germany.Our analysis is based on data from 11 population-based cancer registries, covering 33 million inhabitants. Patients diagnosed with stomach and esophagus cancer in 1997-2006 were included. Period analysis was used to derive five-year relative survival estimates and trends by age, sex, cancer subsite, and stage for the t…

AdultMalemedicine.medical_specialtyEsophageal NeoplasmsPopulationAdenocarcinomaGastroenterologyStomach NeoplasmsGermanyInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingRegistriesSex DistributionEsophagusStage (cooking)educationSurvival analysisAgededucation.field_of_studyRelative survivalbusiness.industryStomachCancerHematologyGeneral MedicineMiddle Agedmedicine.diseaseSurvival AnalysisUnited StatesSurvival Ratemedicine.anatomical_structureOncologyPeriod AnalysisFemaleEsophagogastric JunctionbusinessSEER ProgramActa Oncologica
researchProduct

Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center bi…

2011

Abstract Background Cetuximab plus irinotecan/folinic acid/5-fluorouracil (5-FU) (IF) was evaluated as first-line treatment of patients with advanced gastric cancer and gastroesophageal junction tumors. Preplanned analyses of the influence of tumor biomarkers on treatment outcome were carried out. Patients and methods Patients received weekly cetuximab (400 mg/m2 on day 1, subsequently 250 mg/m2) plus irinotecan (80 mg/m2) and a 24-hour continuous infusion of folinic acid (200 mg/m2) and 5-FU (1500 mg/m2) on days 1, 8, 15, 22, 29 and 36 of a 50-day cycle, until progressive disease (PD). Results The most common grade 3/4 toxic effects in 49 patients were diarrhea (15%) and skin toxic effects…

AdultMalemedicine.medical_specialtyEsophageal Neoplasmsmedicine.drug_classMedizinLeucovorinPhases of clinical researchCetuximabAntibodies Monoclonal HumanizedIrinotecanAntimetaboliteGastroenterologyFolinic acidStomach NeoplasmsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsMedicineHumansProgression-free survivalAgedCetuximabbusiness.industryAntibodies MonoclonalHematologyMiddle Agedmedicine.diseaseSurgeryIrinotecanTreatment OutcomeOncologyFluorouracilCamptothecinFemaleFluorouracilbusinessProgressive diseasemedicine.drugAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Carcinoma of the hypopharynx and the cervical oesophagus: a surgical challenge.

1999

To report our results after reconstruction of the upper digestive tract for locally advanced carcinoma of the hypopharynx and cervical oesophagus.Open study.Teaching University hospital, Germany.Of the 517 patients who presented with carcinoma of the oesophagus between September 1985 and March 1997, 16 had a locally advanced tumour of the hypopharynx and 25 of the cervical oesophagus.Free jejunal grafts were used after circular resection in all patients with carcinoma of the hypopharynx, and for the 3 with oesophageal carcinoma in whom we obtained adequate resection margins. In the remainder stomach was used in 21 and colon in 1.Morbidity and mortality.After jejunal grafting 1 patient died …

AdultMalemedicine.medical_specialtyEsophageal Neoplasmsmedicine.medical_treatmentAnastomosisAdenocarcinomaEsophagusPostoperative ComplicationsHypopharyngeal Neoplasmotorhinolaryngologic diseasesmedicineCarcinomaHumansHospital MortalityEsophagusSurvival rateNeoplasm StagingHypopharyngeal Neoplasmsbusiness.industryStomachdigestive oral and skin physiologyMiddle Agedmedicine.diseaseSurgeryEsophagectomySurvival RateHypopharynxmedicine.anatomical_structureJejunumEsophagectomyCarcinoma Squamous CellAdenocarcinomaSurgeryFemalebusinessThe European journal of surgery = Acta chirurgica
researchProduct

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

2021

BackgroundNo adjuvant treatment has been established for patients who remain at high risk for recurrence after neoadjuvant chemoradiotherapy and surgery for esophageal or gastroesophageal junction cancer. MethodsWe conducted CheckMate 577, a global, randomized, double-blind, placebo-controlled phase 3 trial to evaluate a checkpoint inhibitor as adjuvant therapy in patients with esophageal or gastroesophageal junction cancer. Adults with resected (R0) stage II or III esophageal or gastroesophageal junction cancer who had received neoadjuvant chemoradiotherapy and had residual pathological disease were randomly assigned in a 2:1 ratio to receive nivolumab (at a dose of 240 mg every 2 weeks fo…

AdultMalemedicine.medical_specialtyEsophageal Neoplasmsmedicine.medical_treatment[SDV.CAN]Life Sciences [q-bio]/CancerKaplan-Meier EstimateAdenocarcinoma030204 cardiovascular system & hematologyGastroenterologyB7-H1 AntigenDisease-Free Survival03 medical and health sciences0302 clinical medicineDouble-Blind MethodStomach NeoplasmsInternal medicineMedicine and Health SciencesmedicineCarcinomaHumans030212 general & internal medicineEsophagusImmune Checkpoint InhibitorsNeoadjuvant therapyAgedAged 80 and overChemotherapybusiness.industryCancerChemoradiotherapy AdjuvantGeneral MedicineMiddle Agedmedicine.diseaseNeoadjuvant TherapyIntention to Treat Analysis3. Good healthNivolumabmedicine.anatomical_structureChemotherapy AdjuvantCarcinoma Squamous CellFemaleEsophagogastric JunctionNivolumabbusinessAdjuvantChemoradiotherapyNew England Journal of Medicine
researchProduct

Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease.

2009

Introduction: Functional dyspepsia and non-erosive reflux disease (NERD) are prevalent gastrointestinal conditions with accumulating evidence regarding an overlap between the two. Still, patients with NERD represent a very heterogeneous group and limited data on dyspeptic symptoms in various subgroups of NERD are available. Aim: To evaluate the prevalence of dyspeptic symptoms in patients with NERD subclassified by using 24 h impedance-pH monitoring (MII-pH). Methods: Patients with typical reflux symptoms and normal endoscopy underwent impedance-pH monitoring off proton pump inhibitor treatment. Oesophageal acid exposure time (AET), type of acid and non-acid reflux episodes, and symptom ass…

AdultMalemedicine.medical_specialtyEsophageal pH MonitoringAdolescentNerdmedicine.drug_classProton-pump inhibitorGastroenterologyBody Mass IndexDiagnosis DifferentialYoung AdultEsophagusSex FactorsHeartburnInternal medicinemedicineElectric ImpedanceHumansNERD FD FH SAP1506EsophagusDyspepsiaAgedAnalysis of Variancemedicine.diagnostic_testbusiness.industryEsophageal diseaseStomachdigestive oral and skin physiologyStomachGastroenterologyRefluxHeartburnMiddle Agedmedicine.diseasedigestive system diseasesOesophagusmedicine.anatomical_structureGastroesophageal RefluxFemaleEsophagoscopymedicine.symptombusinessEsophageal pH monitoring
researchProduct